For patients with severe COVID-19 requiring high flow nasal cannula (HFNC), triple therapy of dexamethasone, remdesivir, and baricitinib is associated with significant survival benefit compared with dual therapy, according ...
Aug 12, 2022
0
14
For hospitalized patients with COVID-19 requiring supplemental oxygen, baricitinib plus remdesivir and dexamethasone plus remdesivir result in similar mechanical ventilation-free survival by day 29, but adverse events occur ...
Jun 21, 2022
0
16
Indigenous people in Australia experience three times more vision loss than non-Indigenous people, creating a concerning gap for vision.
Apr 19, 2022
0
2
There is a steadily growing arsenal of drugs for COVID-19. Researchers from Charité-Universitätsmedizin Berlin, the Max Delbrück Center for Molecular Medicine (MDC) and Freie Universität (FU) Berlin have studied the mechanisms ...
Apr 13, 2022
0
4
For individuals hospitalized with COVID-19, continuing treatment with dexamethasone at discharge is not associated with a reduction in 14-day all-cause readmission or mortality, according to a study published online March ...
Mar 9, 2022
0
19
Dexamethasone, a glucocorticoid with anti-inflammatory and immunosuppressive effects, can transiently increase the expression of therapeutic genes delivered using adeno-associated virus (AAV) vectors. A new study, which showed ...
Feb 1, 2022
0
0
An early benefit assessment conducted by the German Institute for Quality and Efficiency in Health Care (IQWiG) in 2020 already addressed the question of whether daratumumab in combination with lenalidomide and dexamethasone ...
Jan 4, 2022
0
14
Use of the steroid, dexamethasone, has been confirmed as a reliable and effective treatment for COVID-19, even in patients with diabetes, according to research to be presented at the Society for Endocrinology annual conference ...
Nov 10, 2021
0
3
Use of the steroid, dexamethasone, has been confirmed as a reliable and effective treatment for COVID-19, even in patients with diabetes, according to research to be presented at the Society for Endocrinology annual conference ...
Nov 9, 2021
0
15
(HealthDay)—The number of days alive without life support at day 28 did not differ among adults with COVID-19 and severe hypoxemia receiving dexamethasone 12 mg/day versus dexamethasone 6 mg/day administered intravenously ...
Oct 29, 2021
0
7
